Dr. Brad Rosenberg is an Assistant Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. His laboratory uses a combination of “wet lab” and computational methods to study immune function in the context of viral infection.
Over the course of his scientific training and career, Brad has studied and worked in diverse areas of biomedical research, including immunology, bioinformatics, RNA editing and infectious disease. He received his Bachelor’s and Master’s degrees from Yale University, where his research focused on the molecular signals that recruit immune cells across blood vessel walls to inflamed tissue. He undertook his graduate training in the Tri-Institutional MD/PhD program jointly administered by Weill-Cornell Medical College, The Rockefeller University, and Memorial Sloan Kettering Institute. Conducting his PhD research in the laboratory of Dr. Nina Papavasiliou, he developed comparative transcriptomics techniques to define new roles for RNA editing by the APOBEC1 cytidine deaminase. Shortly after completing his MD training in 2012, he received the NIH Director’s Early Independence Award and established his independent laboratory as a John C. Whitehead Presidential Fellow at The Rockefeller University. Using an integrative approach that combines experimental immunology, high-throughput DNA sequencing, microfluidic technology, and bioinformatics, his research group aims to learn how the immune system functions in response to viral infections. In 2017, Brad joined the faculty of the Department of Microbiology at Mount Sinai. Here, his laboratory continues to apply innovative genomics technologies, with a focus on high throughput single cell RNA sequencing, to study the host response to viral infection.
In addition to the awards listed above, Dr. Rosenberg is a recipient of the Irma T. Hirschl and Monique Weill-Caulier Trust Research Award. His laboratory is a member of the Virus Engineering Center for Therapeutics and Research (VECToR) at the Icahn School of Medicine at Mount Sinai, and a former member of the NIH-funded Cooperative Center for Human Immunology (CCHI) at the Rockefeller University.